May 17 (Reuters) - Moderna ( MRNA ) has won a case at
the European Patent Office in its dispute with Pfizer ( PFE )
and BioNTech over its COVID-19 vaccine, the Financial
Times reported on Friday.
Moderna ( MRNA ) did not immediately respond to a Reuters request for
comment.
(Reporting by Sriparna Roy in Bengaluru; Editing by Anil
D'Silva)